1. Home
  2. MIST vs SKLZ Comparison

MIST vs SKLZ Comparison

Compare MIST & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • SKLZ
  • Stock Information
  • Founded
  • MIST 2003
  • SKLZ 2012
  • Country
  • MIST Canada
  • SKLZ United States
  • Employees
  • MIST N/A
  • SKLZ N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • SKLZ EDP Services
  • Sector
  • MIST Health Care
  • SKLZ Technology
  • Exchange
  • MIST Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • MIST 89.8M
  • SKLZ 106.4M
  • IPO Year
  • MIST N/A
  • SKLZ N/A
  • Fundamental
  • Price
  • MIST $1.60
  • SKLZ $6.98
  • Analyst Decision
  • MIST Strong Buy
  • SKLZ Buy
  • Analyst Count
  • MIST 2
  • SKLZ 2
  • Target Price
  • MIST $7.50
  • SKLZ $10.75
  • AVG Volume (30 Days)
  • MIST 1.8M
  • SKLZ 55.5K
  • Earning Date
  • MIST 08-07-2025
  • SKLZ 07-31-2025
  • Dividend Yield
  • MIST N/A
  • SKLZ N/A
  • EPS Growth
  • MIST N/A
  • SKLZ N/A
  • EPS
  • MIST N/A
  • SKLZ N/A
  • Revenue
  • MIST N/A
  • SKLZ $92,644,000.00
  • Revenue This Year
  • MIST N/A
  • SKLZ $0.20
  • Revenue Next Year
  • MIST N/A
  • SKLZ $14.10
  • P/E Ratio
  • MIST N/A
  • SKLZ N/A
  • Revenue Growth
  • MIST N/A
  • SKLZ N/A
  • 52 Week Low
  • MIST $0.63
  • SKLZ $3.54
  • 52 Week High
  • MIST $2.75
  • SKLZ $7.50
  • Technical
  • Relative Strength Index (RSI)
  • MIST 83.15
  • SKLZ 63.13
  • Support Level
  • MIST $1.86
  • SKLZ $7.15
  • Resistance Level
  • MIST $1.97
  • SKLZ $7.50
  • Average True Range (ATR)
  • MIST 0.14
  • SKLZ 0.24
  • MACD
  • MIST 0.06
  • SKLZ 0.02
  • Stochastic Oscillator
  • MIST 100.00
  • SKLZ 72.35

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: